Yahoo Web Search

Sign In

Search results

  1. 37.90
    Add to watchlist
    -0.71 (-1.84%)
    At close: Fri. May 10, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
    Full chart
    • Open
      38.69
      High
      38.93
      Low
      37.66
    • Mkt Cap
      2.33B
      P/E (TTM)
      N/A
      Div & Yield
      N/A & N/A
    • Prev. Close
      38.61
      52 Wk. Low
      9.60
      52 Wk. High
      45.31

    More about KYMR

    Top stories

    Related stocks

    More on Yahoo Finance

  2. finance.yahoo.com › quote › KYMRKymera Therapeutics, Inc. (KYMR) - Yahoo Finance

    40.89. -4.80%. Find the latest Kymera Therapeutics, Inc. (KYMR) stock quote, history, news and other vital information to help you with your stock trading and investing.

  3. investors.kymeratx.comKymera Overview | Kymera Therapeutics, Inc.

    May 2, 2024 · Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Stock Information. Data Provided by Refinitiv. Minimum 15 minutes delayed. More Information.

  4. www.google.com › finance › quoteKymera Therapeutics Inc (KYMR) Stock Price & News - Google ...

    Get the latest Kymera Therapeutics Inc (KYMR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  5. www.kymeratx.comRevolutionary Medicines Catalyzed by Protein Degradation ...

    Dec 10, 2023 · Kymeara Therapeutics. Reinventing Medicine. with Protein Degradation. Our Company. Expanding the Range of. Treatable Disease. Kymera is committed to advancing cutting-edge science to develop a new generation of medicines that address critical health problems and dramatically improve patients’ lives by targeting the fundamental drivers of disease.

  6. www.marketwatch.com › investing › stockKYMR Stock Price | Kymera Therapeutics Inc. Stock Quote (U.S ...

    May 2, 2024 · KYMR | Complete Kymera Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

    • 15.43%
    • 3.22%
    • 25.26%
    • 35.25%

  7. Images

    • 生物制药公司：Kymera Therapeutics(KYMR) | 美股之家 | 美股百科 | 美港股开户投资
    • Купить акции Kymera Therapeutics (KYMR) 📈: стоимость сегодня, прогноз ...
    • KYMR Stock Price and Chart — NASDAQ:KYMR — TradingView
    • KYMR Stock Price and Chart — NASDAQ:KYMR — TradingView

    View all

  8. investors.kymeratx.com › news-events › press-releasesPress Releases | Kymera Therapeutics, Inc.

    Mar 8, 2024 · WATERTOWN, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at. Read More. February 22, 2024.

  9. www.kymeratx.com › science-innovation › pipelinePipeline | Kymera Therapeutics

    500 North Beacon Street, 4th Floor, Watertown, MA 02472. © 2024 Kymera Therapeutics. All Rights Reserved. Kymera’s pipeline is focused on validated disease targets where protein degradation is the best or only way to improve the standard of care.

  1. Searches related to KYMR

    kymr stockkymr price
    kymr yahoo financekymr news
    kymr stock pricekymr stock quote
    kymr radio
  2. People also search for